Breaking News Instant updates and real-time market news.

TCBK

TriCo Bancshares

$44.39 /

+1.06 (+2.45%)

17:01
03/01/21
03/01
17:01
03/01/21
17:01

TriCo Bancshares raises quarterly dividend to 25c from 22c per share

The dividend is payable on March 26, 2021 to holders of record on March 12, 2021.

TCBK TriCo Bancshares
$44.39 /

+1.06 (+2.45%)

10/28/20 Stephens
TriCo Bancshares resumed with an Equal Weight at Stephens

TODAY'S FREE FLY STORIES

Hot Stocks
Unisys names Dwayne Allen as Chief Technology Officer » 07:56
04/12/21
04/12
07:56
04/12/21
07:56
UIS

Unisys

$24.11 /

-0.61 (-2.47%)

, MSFT

Microsoft

$255.73 /

+2.37 (+0.94%)

Unisys (UIS) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UIS Unisys
$24.11 /

-0.61 (-2.47%)

MSFT Microsoft
$255.73 /

+2.37 (+0.94%)

UIS Unisys
$24.11 /

-0.61 (-2.47%)

12/07/20 Sidoti
Unisys reinstated with a Buy at Sidoti
MSFT Microsoft
$255.73 /

+2.37 (+0.94%)

07:36 Today B. Riley
Nuance possible takeout positive for peer LivePerson, says B. Riley
07:29 Today Wedbush
Nuance deal would be 'trophy' for Microsoft, says Wedbush
07:11 Today BMO Capital
Microsoft price target raised to $280 from $270 at BMO Capital
04/09/21 BTIG
Okta upgraded to Buy from Neutral at BTIG
UIS Unisys
$24.11 /

-0.61 (-2.47%)

MSFT Microsoft
$255.73 /

+2.37 (+0.94%)

MSFT Microsoft
$255.73 /

+2.37 (+0.94%)

UIS Unisys
$24.11 /

-0.61 (-2.47%)

MSFT Microsoft
$255.73 /

+2.37 (+0.94%)

MSFT Microsoft
$255.73 /

+2.37 (+0.94%)

Initiation
Radius Global Infrastructure initiated with a Buy at Jefferies » 07:56
04/12/21
04/12
07:56
04/12/21
07:56
RADI

Radius Global Infrastructure

$15.47 /

+0.3 (+1.98%)

Jefferies analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RADI Radius Global Infrastructure
$15.47 /

+0.3 (+1.98%)

12/29/20 LightShed Partners
Radius Global Infrastructure initiated with a Buy at LightShed Partners
12/22/20
Fly Intel: Top five analyst initiations
12/22/20 Credit Suisse
Radius Global Infrastructure initiated with an Outperform at Credit Suisse
Conference/Events
Jefferies technology specialist to hold analyst/industry conference call » 07:55
04/12/21
04/12
07:55
04/12/21
07:55

Technology Specialist…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
iTeos Therapeutics to hold a conference call » 07:55
04/12/21
04/12
07:55
04/12/21
07:55
ITOS

iTeos Therapeutics

$26.99 /

-3.12 (-10.36%)

Management discusses…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ITOS iTeos Therapeutics
$26.99 /

-3.12 (-10.36%)

ITOS iTeos Therapeutics
$26.99 /

-3.12 (-10.36%)

04/09/21 Piper Sandler
AACR abstracts a 'win' for iTeos Therapeutics, says Piper Sandler
04/05/21 Piper Sandler
Piper Sandler continues to recommend iTeos Therapeutics into data
03/25/21 Wedbush
iTeos Therapeutics price target raised to $52 from $46 at Wedbush
10/07/20 Baird
iTeos Therapeutics initiated with an Outperform at Baird
ITOS iTeos Therapeutics
$26.99 /

-3.12 (-10.36%)

  • 24
    Jul
Conference/Events
Blueprint Medicines to host conference call » 07:55
04/12/21
04/12
07:55
04/12/21
07:55
BPMC

Blueprint Medicines

$94.14 /

+0.25 (+0.27%)

Management reviews new…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BPMC Blueprint Medicines
$94.14 /

+0.25 (+0.27%)

BPMC Blueprint Medicines
$94.14 /

+0.25 (+0.27%)

04/09/21 Piper Sandler
AACR abstracts a 'win' for iTeos Therapeutics, says Piper Sandler
03/30/21 Credit Suisse
Blueprint Medicines initiated with a Neutral at Credit Suisse
03/30/21 Credit Suisse
Blueprint Medicines initiated with a Neutral at Credit Suisse
02/18/21 Barclays
Blueprint Medicines price target raised to $95 from $90 at Barclays
BPMC Blueprint Medicines
$94.14 /

+0.25 (+0.27%)

Downgrade
Yaskawa Electric downgraded to Hold from Buy at Jefferies » 07:54
04/12/21
04/12
07:54
04/12/21
07:54
YASKY

Yaskawa Electric

$107.20 /

-0.89 (-0.82%)

Jefferies analyst Sho…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
YASKY Yaskawa Electric
$107.20 /

-0.89 (-0.82%)

01/04/21 Goldman Sachs
Yaskawa Electric upgraded to Buy from Neutral at Goldman Sachs
10/22/20 SMBC Nikko
Yaskawa Electric upgraded to Neutral from Underperform at SMBC Nikko
07/21/20 Daiwa
Yaskawa Electric downgraded to Neutral from Outperform at Daiwa
Hot Stocks
Alibaba affiliate Ant Group announces overhaul » 07:54
04/12/21
04/12
07:54
04/12/21
07:54
BABA

Alibaba

$223.35 /

-4.9 (-2.15%)

Alibaba affiliate Ant…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BABA Alibaba
$223.35 /

-4.9 (-2.15%)

BABA Alibaba
$223.35 /

-4.9 (-2.15%)

07:37 Today Raymond James
Alibaba price target lowered to $330 from $350 at Raymond James
06:41 Today Mizuho
Alibaba antitrust ruling 'removes overhang,' says Mizuho
06:37 Today Citi
Alibaba fine could help lift 'overhang' on shares, says Citi
06:36 Today KeyBanc
Alibaba price target lowered to $305 from $315 at KeyBanc
BABA Alibaba
$223.35 /

-4.9 (-2.15%)

BABA Alibaba
$223.35 /

-4.9 (-2.15%)

BABA Alibaba
$223.35 /

-4.9 (-2.15%)

BABA Alibaba
$223.35 /

-4.9 (-2.15%)

Upgrade
Jefferies upgrades Evelo Biosciences to Buy on increased microbiome momentum » 07:52
04/12/21
04/12
07:52
04/12/21
07:52
EVLO

Evelo Biosciences

$10.03 /

+0.005 (+0.05%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVLO Evelo Biosciences
$10.03 /

+0.005 (+0.05%)

EVLO Evelo Biosciences
$10.03 /

+0.005 (+0.05%)

04:50 Today Jefferies
Evelo Biosciences upgraded to Buy from Hold at Jefferies
03/12/21 Chardan
Evelo Biosciences price target raised to $15 from $10 at Chardan
01/25/21 JMP Securities
Evelo Biosciences price target raised to $36 from $27 at JMP Securities
12/30/20 JMP Securities
Evelo shares undervalued into atopic dermatitis data, says JMP Securities
EVLO Evelo Biosciences
$10.03 /

+0.005 (+0.05%)

  • 29
    Jan
  • 25
    Jun
EVLO Evelo Biosciences
$10.03 /

+0.005 (+0.05%)

Initiation
Duckhorn Portfolio initiated with a Buy at Jefferies » 07:48
04/12/21
04/12
07:48
04/12/21
07:48
NAPA

Duckhorn Portfolio

$18.89 /

+0.785 (+4.34%)

Jefferies analyst Kevin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NAPA Duckhorn Portfolio
$18.89 /

+0.785 (+4.34%)

07:19 Today JPMorgan
Duckhorn Portfolio initiated with an Overweight at JPMorgan
06:48 Today Citi
Duckhorn Portfolio initiated with a Buy at Citi
06:44 Today Evercore ISI
Duckhorn Portfolio initiated with an Outperform at Evercore ISI
06:24 Today Credit Suisse
Duckhorn Portfolio initiated with an Outperform at Credit Suisse
  • 18
    Mar
NAPA Duckhorn Portfolio
$18.89 /

+0.785 (+4.34%)

NAPA Duckhorn Portfolio
$18.89 /

+0.785 (+4.34%)

Hot Stocks
Jazz Pharmaceuticals: FDA grants Priority Review of sNDA for Xywav » 07:48
04/12/21
04/12
07:48
04/12/21
07:48
JAZZ

Jazz Pharmaceuticals

$161.34 /

+0.43 (+0.27%)

Jazz Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JAZZ Jazz Pharmaceuticals
$161.34 /

+0.43 (+0.27%)

JAZZ Jazz Pharmaceuticals
$161.34 /

+0.43 (+0.27%)

04/06/21 RBC Capital
Jazz Pharmaceuticals transferred with an Outperform at RBC Capital
04/01/21 Morgan Stanley
Jazz Pharmaceuticals price target raised to $176 from $162 at Morgan Stanley
03/01/21 UBS
Jazz Pharmaceuticals price target raised to $228 from $174 at UBS
02/24/21 Cowen
Jazz Pharmaceuticals price target raised to $200 from $190 at Cowen
JAZZ Jazz Pharmaceuticals
$161.34 /

+0.43 (+0.27%)

JAZZ Jazz Pharmaceuticals
$161.34 /

+0.43 (+0.27%)

JAZZ Jazz Pharmaceuticals
$161.34 /

+0.43 (+0.27%)

Hot Stocks
Beyond Meat announces product distribution expansion with European retailers » 07:48
04/12/21
04/12
07:48
04/12/21
07:48
BYND

Beyond Meat

$130.24 /

-4.45 (-3.30%)

Beyond Meat announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BYND Beyond Meat
$130.24 /

-4.45 (-3.30%)

BYND Beyond Meat
$130.24 /

-4.45 (-3.30%)

04/07/21 Piper Sandler
Piper Sandler survey shows more teens open to plant-based meat
04/05/21 JPMorgan
BellRing, Hostess among JPMorgan's 'Own Now' names in food
03/19/21
Fly Intel: Top five analyst initiations
03/18/21 Stephens
Stephens starts Beyond Meat at buy with alternative protein 'going mainstream'
BYND Beyond Meat
$130.24 /

-4.45 (-3.30%)

BYND Beyond Meat
$130.24 /

-4.45 (-3.30%)

BYND Beyond Meat
$130.24 /

-4.45 (-3.30%)

BYND Beyond Meat
$130.24 /

-4.45 (-3.30%)

Earnings
InMode sees Q1 adjusted EPS 65c-67c, consensus 46c » 07:46
04/12/21
04/12
07:46
04/12/21
07:46
INMD

InMode

$80.64 /

-0.19 (-0.24%)

Sees Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INMD InMode
$80.64 /

-0.19 (-0.24%)

INMD InMode
$80.64 /

-0.19 (-0.24%)

02/11/21 Baird
InMode price target raised to $84 from $58 at Baird
02/11/21 Canaccord
InMode price target raised to $80 from $69 at Canaccord
02/11/21 UBS
InMode price target raised to $84 from $64 at UBS
10/21/20 Canaccord
InMode price target raised to $51 from $42 at Canaccord
INMD InMode
$80.64 /

-0.19 (-0.24%)

INMD InMode
$80.64 /

-0.19 (-0.24%)

Hot Stocks
Centerra Gold to list common shares on NYSE » 07:45
04/12/21
04/12
07:45
04/12/21
07:45
CGAU

Centerra Gold

/

+

Centerra Gold is pleased…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
PROG Holdings price target lowered to $58 from $65 at Truist » 07:45
04/12/21
04/12
07:45
04/12/21
07:45
PRG

PROG Holdings

$43.93 /

+0.5 (+1.15%)

Truist analyst Bill…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRG PROG Holdings
$43.93 /

+0.5 (+1.15%)

PRG PROG Holdings
$43.93 /

+0.5 (+1.15%)

02/24/21 Stephens
Aaron's peers also potentially received California inquiry, says Stephens
12/22/20 Raymond James
Rent-A-Center price target raised to $45 from $38 at Raymond James
12/22/20 Stephens
Rent-A-Center price target raised to $52 from $45 at Stephens
12/14/20 Berenberg
Aaron's initiated with a Buy at Berenberg
PRG PROG Holdings
$43.93 /

+0.5 (+1.15%)

PRG PROG Holdings
$43.93 /

+0.5 (+1.15%)

Hot Stocks
Cytokinetics announces preclinical data for CK-3773274 » 07:45
04/12/21
04/12
07:45
04/12/21
07:45
CYTK

Cytokinetics

$24.17 /

+0.01 (+0.04%)

Cytokinetics announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CYTK Cytokinetics
$24.17 /

+0.01 (+0.04%)

CYTK Cytokinetics
$24.17 /

+0.01 (+0.04%)

03/11/21 Wolfe Research
Cytokinetics initiated with an Outperform at Wolfe Research
02/18/21 Barclays
Cytokinetics initiated with an Overweight at Barclays
01/20/21 H.C. Wainwright
Cytokinetics price target raised to $41 from $22 at H.C. Wainwright
12/28/20 Oppenheimer
Amgen price target lowered to $266 from $274 at Oppenheimer
CYTK Cytokinetics
$24.17 /

+0.01 (+0.04%)

  • 17
    Jul
CYTK Cytokinetics
$24.17 /

+0.01 (+0.04%)

Initiation
Vine Energy initiated with an Overweight at Morgan Stanley » 07:44
04/12/21
04/12
07:44
04/12/21
07:44
VEI

Vine Energy

$12.11 /

+0.11 (+0.92%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VEI Vine Energy
$12.11 /

+0.11 (+0.92%)

06:50 Today Citi
Vine Energy initiated with a Buy at Citi
06:22 Today Barclays
Vine Energy initiated with an Equal Weight at Barclays
06:17 Today RBC Capital
Vine Energy initiated with an Outperform at RBC Capital
06:16 Today BofA
Vine Energy initiated with a Buy at BofA
  • 18
    Mar
VEI Vine Energy
$12.11 /

+0.11 (+0.92%)

Hot Stocks
OpGen announces results from webinar on bacterial pneumonia co-infections » 07:42
04/12/21
04/12
07:42
04/12/21
07:42
OPGN

OpGen

$2.68 /

-0.045 (-1.65%)

OpGen announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OPGN OpGen
$2.68 /

-0.045 (-1.65%)

OPGN OpGen
$2.68 /

-0.045 (-1.65%)

03/02/21 Alliance Global Partners
Alliance Global raises OpGen price target to $7, sees 'eventful 2021'
11/13/20 Alliance Global Partners
OpGen price target raised to $5.65 from $5.00 at Alliance Global Partners
06/09/20 Alliance Global Partners
Alliance Global Partners sees OpGen preliminary data as positive
06/03/20 Alliance Global Partners
OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global
OPGN OpGen
$2.68 /

-0.045 (-1.65%)

OPGN OpGen
$2.68 /

-0.045 (-1.65%)

Hot Stocks
Intellia Therapeutics appoints Georgia Keresty to board of directors » 07:41
04/12/21
04/12
07:41
04/12/21
07:41
NTLA

Intellia Therapeutics

$70.54 /

-2.33 (-3.20%)

, TAK

Takeda Pharmaceutical

$17.25 /

+0.195 (+1.14%)

, AZPN

Aspen Technology

$153.02 /

-1.02 (-0.66%)

, SLDB

Solid Biosciences

$5.20 /

-0.17 (-3.17%)

Intellia Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTLA Intellia Therapeutics
$70.54 /

-2.33 (-3.20%)

TAK Takeda Pharmaceutical
$17.25 /

+0.195 (+1.14%)

AZPN Aspen Technology
$153.02 /

-1.02 (-0.66%)

SLDB Solid Biosciences
$5.20 /

-0.17 (-3.17%)

NTLA Intellia Therapeutics
$70.54 /

-2.33 (-3.20%)

03/04/21 JMP Securities
Intellia Therapeutics initiated with an Outperform at JMP Securities
02/26/21 Truist
Intellia Therapeutics price target raised to $80 from $40 at Truist
02/10/21 Chardan
Intellia Therapeutics price target raised to $85 from $57.50 at Chardan
01/08/21 Barclays
Intellia Therapeutics price target raised to $90 from $46 at Barclays
TAK Takeda Pharmaceutical
$17.25 /

+0.195 (+1.14%)

04/05/21
Fly Intel: Top five analyst downgrades
04/05/21 Barclays
Molecular Templates MT-3724 discontinuation shouldn't be surprise, says Barclays
04/05/21 Jefferies
Takeda Pharmaceutical downgraded to Hold from Buy at Jefferies
03/03/21 RBC Capital
Ovid downgraded to Sector Perform at RBC Capital after rally on Takeda deal
AZPN Aspen Technology
$153.02 /

-1.02 (-0.66%)

02/16/21 KeyBanc
Aspen Technology price target raised to $180 from $158 at KeyBanc
02/03/21 Baird
Aspen Technology upgraded to Outperform from Neutral at Baird
01/05/21 Benchmark
GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
09/23/20 BofA
Aspen Technology reinstated with a Neutral at BofA
SLDB Solid Biosciences
$5.20 /

-0.17 (-3.17%)

03/16/21 Chardan
Solid Biosciences price target raised to $20 from $12.50 at Chardan
03/16/21
Fly Intel: Top five analyst upgrades
03/16/21 SVB Leerink
Solid Biosciences upgraded to Outperform at SVB Leerink
03/16/21 SVB Leerink
Solid Biosciences upgraded to Outperform from Market Perform at SVB Leerink
NTLA Intellia Therapeutics
$70.54 /

-2.33 (-3.20%)

TAK Takeda Pharmaceutical
$17.25 /

+0.195 (+1.14%)

AZPN Aspen Technology
$153.02 /

-1.02 (-0.66%)

SLDB Solid Biosciences
$5.20 /

-0.17 (-3.17%)

  • 19
    Mar
  • 02
    Dec
  • 03
    Jun
NTLA Intellia Therapeutics
$70.54 /

-2.33 (-3.20%)

TAK Takeda Pharmaceutical
$17.25 /

+0.195 (+1.14%)

SLDB Solid Biosciences
$5.20 /

-0.17 (-3.17%)

TAK Takeda Pharmaceutical
$17.25 /

+0.195 (+1.14%)

Hot Stocks
Platinum Equity to acquire Club Car from Ingersoll Rand for $1.7B » 07:40
04/12/21
04/12
07:40
04/12/21
07:40
IR

Ingersoll-Rand

$50.59 /

+0.255 (+0.51%)

Platinum Equity announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IR Ingersoll-Rand
$50.59 /

+0.255 (+0.51%)

IR Ingersoll-Rand
$50.59 /

+0.255 (+0.51%)

04/06/21 Barclays
Ingersoll-Rand price target raised to $56 from $53 at Barclays
02/24/21 Deutsche Bank
Ingersoll-Rand price target raised to $50 from $47 at Deutsche Bank
02/16/21 UBS
Ingersoll-Rand's deal to sell HPS interest 'positive,' says UBS
01/15/21 Jefferies
Ingersoll-Rand price target raised to $53 from $45 at Jefferies
IR Ingersoll-Rand
$50.59 /

+0.255 (+0.51%)

  • 17
    Jun
IR Ingersoll-Rand
$50.59 /

+0.255 (+0.51%)

General news
Treasury Market Outlook: U.S. markets are little changed but still slightly underwater » 07:40
04/12/21
04/12
07:40
04/12/21
07:40
$ECON

Economic Data

/

+

Treasury Market Outlook:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
    Recommendations
    Southwest price target raised to $71 from $54 at Raymond James » 07:40
    04/12/21
    04/12
    07:40
    04/12/21
    07:40
    LUV

    Southwest

    $63.41 /

    -0.06 (-0.09%)

    Raymond James analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    LUV Southwest
    $63.41 /

    -0.06 (-0.09%)

    LUV Southwest
    $63.41 /

    -0.06 (-0.09%)

    04/06/21 Morgan Stanley
    Southwest price target raised to $80 from $59 at Morgan Stanley
    03/30/21 Jefferies
    Southwest price target raised to $70 from $55 at Jefferies
    03/23/21
    Fly Intel: Top five analyst upgrades
    03/23/21 Argus
    Southwest upgraded to Buy from Hold at Argus
    LUV Southwest
    $63.41 /

    -0.06 (-0.09%)

    • 29
      Apr
    LUV Southwest
    $63.41 /

    -0.06 (-0.09%)

    LUV Southwest
    $63.41 /

    -0.06 (-0.09%)

    LUV Southwest
    $63.41 /

    -0.06 (-0.09%)

    Hot Stocks
    Intra-Cellular announces presentation on PDE1 inhibitor program » 07:39
    04/12/21
    04/12
    07:39
    04/12/21
    07:39
    ITCI

    Intra-Cellular

    $31.68 /

    +0.17 (+0.54%)

    Intra-Cellular Therapies…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    ITCI Intra-Cellular
    $31.68 /

    +0.17 (+0.54%)

    ITCI Intra-Cellular
    $31.68 /

    +0.17 (+0.54%)

    12/29/20 Cantor Fitzgerald
    Intra-Cellular price target raised to $54 from $53 at Cantor Fitzgerald
    12/15/20
    Fly Intel: Top five analyst initiations
    12/15/20 BofA
    Intra-Cellular initiated with a Buy at BofA
    12/10/20
    Fly Intel: Top five analyst initiations
    ITCI Intra-Cellular
    $31.68 /

    +0.17 (+0.54%)

    • 11
      Sep
    Earnings
    United Airlines sees Q1 revenue $3.2B, consensus $3.29B » 07:39
    04/12/21
    04/12
    07:39
    04/12/21
    07:39
    UAL

    United Airlines

    $58.43 /

    -0.99 (-1.67%)

    In a regulatory filing,…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    UAL United Airlines
    $58.43 /

    -0.99 (-1.67%)

    UAL United Airlines
    $58.43 /

    -0.99 (-1.67%)

    04/06/21
    Fly Intel: Top five analyst upgrades
    04/06/21 Morgan Stanley
    Morgan Stanley sees further airline upside, upgrades United and Alaska Air
    04/06/21 Morgan Stanley
    United Airlines upgraded to Equal Weight from Underweight at Morgan Stanley
    03/30/21 Jefferies
    United Airlines price target raised to $60 from $55 at Jefferies
    UAL United Airlines
    $58.43 /

    -0.99 (-1.67%)

    • 22
      Apr
    UAL United Airlines
    $58.43 /

    -0.99 (-1.67%)

    UAL United Airlines
    $58.43 /

    -0.99 (-1.67%)

    UAL United Airlines
    $58.43 /

    -0.99 (-1.67%)

    Recommendations
    Mohawk Industries price target raised to $235 from $200 at Raymond James » 07:38
    04/12/21
    04/12
    07:38
    04/12/21
    07:38
    MHK

    Mohawk Industries

    $202.93 /

    +4.795 (+2.42%)

    Raymond James analyst Sam…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    MHK Mohawk Industries
    $202.93 /

    +4.795 (+2.42%)

    MHK Mohawk Industries
    $202.93 /

    +4.795 (+2.42%)

    04/07/21 JPMorgan
    JPMorgan lays out long and short homebuilding ideas into earnings
    03/17/21 Wolfe Research
    Mohawk Industries initiated with a Peer Perform at Wolfe Research
    03/16/21 Wolfe Research
    Mohawk Industries initiated with a Peer Perform at Wolfe Research
    02/18/21
    Fly Intel: Top five analyst upgrades
    MHK Mohawk Industries
    $202.93 /

    +4.795 (+2.42%)

    MHK Mohawk Industries
    $202.93 /

    +4.795 (+2.42%)

    MHK Mohawk Industries
    $202.93 /

    +4.795 (+2.42%)

    Recommendations
    Medavail price target raised to $20 from $18 at Cowen » 07:38
    04/12/21
    04/12
    07:38
    04/12/21
    07:38
    MDVL

    Medavail

    $13.04 /

    -0.06 (-0.46%)

    Cowen analyst Charles…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    MDVL Medavail
    $13.04 /

    -0.06 (-0.46%)

    04/05/21 Cowen
    Medavail price target raised to $18 from $17 at Cowen
    12/14/20 Lake Street
    Medavail initiated with a Buy at Lake Street
    12/14/20 Cowen
    Medavail initiated with an Outperform at Cowen
    MDVL Medavail
    $13.04 /

    -0.06 (-0.46%)

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.